Furthermore, immunohistochemical analysis revealed that compound 968 treatment significantly reduced the number of proliferative Ki-67-positive synovial cells (Fig. 6d and e), suggesting that GLS1 inhibition directly affects the cell-cycle progression of RA-FLS. Here, MKI67 is linked to rheumatoid arthritis.